Receive alerts
Unlisted (UK)
Market Cap:
52 weeks high
52 weeks low

In brief

SMARTCO Research is a market terminal focused on AIM listed and pre-IPO (ie within two years of targeting IPO) companies conforming to an investment template developed by Charles Breese (SMARTCOs). It is a component of Larpent Newton’s SMARTCO Select investment services.

SMARTCO Research is a component of the SMARTCO Select service developed by Charles Breese’s company, Larpent Newton, to provide an investment service to investors interested in investing in SMARTCOs at an annual subscription is £250 pa (incl of VAT) offering the following benefits:

email alerts re new content added to www.SMARTCOresearch.com.
weekly newsletter
access to Audiovisual Content and research from, inter alia, Hardman & Co.
invitations to participate in fundraisings by SMARTCos which are within two years of targeting to IPO or are AIM listed
invitations to attend SMARTCO presentations organised by, inter alia, Hardman & Co.
enabling private investors to be treated similarly to institutional investors whilst being left in control of their investment decisions.

SMARTCOs with Proactive Investors content are:

i) AIM listed:

- AB Dynamics 

- accesso Technology

- Brady

- Cohort

- Collagen Solutions

- Dillistone Group


- Haydale Graphene Industries

- Horizon Discovery Group

- Image Scan

- Instem

- OptiBiotix

- Plastics Capital


- ReNeuron Group

- Scancell Holdings

Stadium Group

- StatPro Group

- Venn Life Science Holdings

ii) Unquoted:

- OR Productivity


The guiding principles of SMARTCO Select were forged in the white heat of Sheffield’s steel industry, according to founder Charles Breese.